Qube Research & Technologies (QRT)
OSCR icon

Qube Research & Technologies (QRT)’s Oscar Health OSCR Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio OSCR Stock Details OSCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$30.9M Buy
1,083,939
+1,015,003
+1,472% +$21.9M 0.03% 701
2026
Q1 		$791K Buy
+68,936
New +$971K ﹤0.01% 2585
2025
Q2 		– Sell
-587,438
Closed -$7.7M – 3856
2025
Q1 		$7.7M Sell
587,438
-93,297
-14% -$1.39M 0.01% 1288
2024
Q4 		$9.15M Sell
680,735
-613,602
-47% -$9.88M 0.01% 1147
2024
Q3 		$27.5M Buy
1,294,337
+451,836
+54% +$8.14M 0.04% 536
2024
Q2 		$13.3M Buy
842,501
+199,934
+31% +$3.67M 0.02% 795
2024
Q1 		$9.55M Buy
642,567
+541,745
+537% +$7.42M 0.02% 876
2023
Q4 		$923K Buy
100,822
+54,083
+116% +$373K ﹤0.01% 1974
2023
Q3 		$260K Buy
+46,739
New +$327K ﹤0.01% 2304
2023
Q1 		– Sell
-220,576
Closed -$543K – 2887
2022
Q4 		$543K Buy
+220,576
New +$689K ﹤0.01% 1439

Other funds holding OSCR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
TCMNY
Thrive Capital Management (New York) New York $3.81B AUM 45.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Qube Research & Technologies (QRT)'s OSCR Position: Q2 2026 in Review

Qube Research & Technologies (QRT) increased its Oscar Health (OSCR) stake by 1,472% in Q2 2026, buying an estimated $21.9M and bringing the position to 1,083,939 shares worth $30.9M. The position accounts for 0.03% of the portfolio, ranked #701.

Qube Research & Technologies (QRT) first reported a position in OSCR in Q4 2022 and has held it in 10 quarters since. 403 funds tracked by Wall St. Rank hold OSCR as of Q2 2026.

  • Qube Research & Technologies (QRT) held 1,083,939 shares of Oscar Health worth $30.9M as of Q2 2026.
  • Qube Research & Technologies (QRT) bought 1,015,003 Oscar Health shares in Q2 2026, an estimated $21.9M.
  • Oscar Health made up 0.03% of Qube Research & Technologies (QRT)'s portfolio in Q2 2026, its #701 holding.
  • Qube Research & Technologies (QRT) first reported a position in Oscar Health in Q4 2022 and has held it in 10 quarters since.
  • 403 funds tracked by Wall St. Rank held Oscar Health as of Q2 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2026, filed 14 Aug 2026.